apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders (2018) Kaehler KC, Eigentler TK, Gesierich A, Heinzerling L, Loquai C, Meier F, Meiss F, et al. Journal article Willingness to pay for a cure of low-risk melanoma patients in Germany (2018) Augustin M, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al. Journal article The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians (2018) Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al. Journal article Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy (2018) Tajmir-Riahi A, Bergmann T, Schmid M, Agaimy A, Schuler G, Heinzerling L Journal article Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab (2017) Brueggemann C, Kirchberger MC, Goldinger SM, Weide B, Konrad A, Erdmann M, Schadendorf D, et al. Journal article Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients (2017) Gross S, Erdmann M, Haendle I, Voland S, Berger T, Schultz E, Strasser E, et al. Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2017) Boßerhoff AK, Schuler G, Heinzerling L, Schilling B, Haferrkamp S, Kirchberger M Conference contribution, Conference Contribution Fear of progression in patients with low-risk malignant melanoma (2017) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Conference contribution BRAF and MEK inhibitors influence human immune cell phenotype and function (2017) Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al. Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution